FDA Inspection 1181345 — ABBOTT DIABETES CARE LIMITED
The FDA completed an inspection of ABBOTT DIABETES CARE LIMITED on Sep 8, 2022 in Witney. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 8, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Witney (United Kingdom)